Governor Wes Moore announced on November 21, 2025, that AstraZeneca, a global biopharmaceutical company, will invest $2 billion to expand its manufacturing footprint across Maryland. The investment ...

Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Identify research insights to guide ...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announces plans to invest $2 billion to expand its long-standing manufacturing footprint in Maryland. This includes a significant expansion of its ...

AstraZeneca said on Friday it will invest $2 billion to expand its manufacturing footprint in Maryland as part of its previously announced $50 billion plan to expand manufacturing and research ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The expansion, which follows a ...

C ambridge, UK-based AstraZeneca plans to invest $2 billion to expand its long-standing manufacturing footprint in Maryland. The project includes an expansion of its flagship biologics manufacturing ...

AstraZeneca says it expects to invest $2 billion to expand its long-standing manufacturing footprint in Maryland. This includes a significant expansion of its flagship biologics manufacturing facility ...

AstraZeneca said it plans to invest $50 billion in the U.S. by 2030, including a proposal for a new drug substance manufacturing center focused on weight-loss drugs. The U.K. biopharmaceutical giant ...